What are you looking for?

Need help finding what you are looking for? Contact Us

Compare

Free Samples

Home Market Research Reports Pharmaceutical

Respiratory

PUBLISHER: TechNavio | PRODUCT CODE: 1524898

PUBLISHER: TechNavio | PRODUCT CODE: 1524898

Global pulmonary embolism therapeutics market 2024-2028

PUBLISHED: July 3, 2024

PAGES: 164 Pages

DELIVERY TIME: 1-2 business days

ADD TO COMPARE

SELECT AN OPTION

The pulmonary embolism therapeutics market is forecasted to grow by USD 14020.7 mn during 2023-2028, accelerating at a CAGR of 10.93% during the forecast period. The report on the pulmonary embolism therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing risk of adverse health conditions, increase in geriatric population, and rise in research and development activities for pulmonary embolism therapeutics.

Technavio's pulmonary embolism therapeutics market is segmented as below:

Market Scope
Base Year	2024
End Year	2028
Series Year	2024-2028
Growth Momentum	Accelerate
YOY 2024	9.57%
CAGR	10.93%
Incremental Value	$14020.7mn

By Application

Hospitals
Ambulatory surgical centers
Research institutes

By Route Of Administration

Oral
Parenteral

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the advancements in healthcare and medical sector as one of the prime reasons driving the pulmonary embolism therapeutics market growth during the next few years. Also, increasing awareness regarding pulmonary embolism and growing number of partnerships and collaborations on therapeutics will lead to sizable demand in the market.

The report on the pulmonary embolism therapeutics market covers the following areas:

Pulmonary embolism therapeutics market sizing
Pulmonary embolism therapeutics market forecast
Pulmonary embolism therapeutics market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading pulmonary embolism therapeutics market vendors that include AbbVie Inc., Amgen Inc., Anthos Therapeutics, argenx SE, Astellas Pharma Inc., Bayer AG, Boehringer Ingelheim International GmbH, Bristol Myers Squibb Co., Daiichi Sankyo Co. Ltd., Eli Lilly and Co., F. Hoffmann La Roche Ltd., Gilead Sciences Inc., Inari Medical Inc., Johnson and Johnson Services Inc., Medtronic Plc, Novartis AG, Pfizer Inc., Sanofi SA, Takeda Pharmaceutical Co. Ltd., and Viatris Inc.. Also, the pulmonary embolism therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Product Code: IRTNTR75721

1 Executive Summary

1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market By Geographical Landscape
- Executive Summary - Chart on Market Segmentation by Application
- Executive Summary - Chart on Market Segmentation by Route of Administration
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning

2 Market Landscape

2.1 Market ecosystem
- Parent Market
- Data Table on - Parent Market
2.2 Market characteristics
- Market characteristics analysis
2.3 Value chain analysis
- Value Chain Analysis

3 Market Sizing

3.1 Market definition
- Offerings of companies included in the market definition
3.2 Market segment analysis
- Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
- Chart on Global - Market size and forecast 2023-2028 ($ million)
- Data Table on Global - Market size and forecast 2023-2028 ($ million)
- Chart on Global Market: Year-over-year growth 2023-2028 (%)
- Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

4.1 Global Pulmonary Embolism Therapeutics Market 2018 - 2022
- Historic Market Size - Data Table on Global Pulmonary Embolism Therapeutics Market 2018 - 2022 ($ million)
4.2 Application segment analysis 2018 - 2022
- Historic Market Size - Application Segment 2018 - 2022 ($ million)
4.3 Route of Administration segment analysis 2018 - 2022
- Historic Market Size - Route of Administration Segment 2018 - 2022 ($ million)
4.4 Geography segment analysis 2018 - 2022
- Historic Market Size - Geography Segment 2018 - 2022 ($ million)
4.5 Country segment analysis 2018 - 2022
- Historic Market Size - Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis

5.1 Five forces summary
- Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
- Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Application

6.1 Market segments
- Chart on Application - Market share 2023-2028 (%)
- Data Table on Application - Market share 2023-2028 (%)
6.2 Comparison by Application
- Chart on Comparison by Application
- Data Table on Comparison by Application
6.3 Hospitals - Market size and forecast 2023-2028
- Chart on Hospitals - Market size and forecast 2023-2028 ($ million)
- Data Table on Hospitals - Market size and forecast 2023-2028 ($ million)
- Chart on Hospitals - Year-over-year growth 2023-2028 (%)
- Data Table on Hospitals - Year-over-year growth 2023-2028 (%)
6.4 Ambulatory surgical centers - Market size and forecast 2023-2028
- Chart on Ambulatory surgical centers - Market size and forecast 2023-2028 ($ million)
- Data Table on Ambulatory surgical centers - Market size and forecast 2023-2028 ($ million)
- Chart on Ambulatory surgical centers - Year-over-year growth 2023-2028 (%)
- Data Table on Ambulatory surgical centers - Year-over-year growth 2023-2028 (%)
6.5 Research institutes - Market size and forecast 2023-2028
- Chart on Research institutes - Market size and forecast 2023-2028 ($ million)
- Data Table on Research institutes - Market size and forecast 2023-2028 ($ million)
- Chart on Research institutes - Year-over-year growth 2023-2028 (%)
- Data Table on Research institutes - Year-over-year growth 2023-2028 (%)
6.6 Market opportunity by Application
- Market opportunity by Application ($ million)
- Data Table on Market opportunity by Application ($ million)

7 Market Segmentation by Route of Administration

7.1 Market segments
- Chart on Route of Administration - Market share 2023-2028 (%)
- Data Table on Route of Administration - Market share 2023-2028 (%)
7.2 Comparison by Route of Administration
- Chart on Comparison by Route of Administration
- Data Table on Comparison by Route of Administration
7.3 Oral - Market size and forecast 2023-2028
- Chart on Oral - Market size and forecast 2023-2028 ($ million)
- Data Table on Oral - Market size and forecast 2023-2028 ($ million)
- Chart on Oral - Year-over-year growth 2023-2028 (%)
- Data Table on Oral - Year-over-year growth 2023-2028 (%)
7.4 Parenteral - Market size and forecast 2023-2028
- Chart on Parenteral - Market size and forecast 2023-2028 ($ million)
- Data Table on Parenteral - Market size and forecast 2023-2028 ($ million)
- Chart on Parenteral - Year-over-year growth 2023-2028 (%)
- Data Table on Parenteral - Year-over-year growth 2023-2028 (%)
7.5 Market opportunity by Route of Administration
- Market opportunity by Route of Administration ($ million)
- Data Table on Market opportunity by Route of Administration ($ million)

8 Customer Landscape

8.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

9.1 Geographic segmentation
- Chart on Market share By Geographical Landscape 2023-2028 (%)
- Data Table on Market share By Geographical Landscape 2023-2028 (%)
9.2 Geographic comparison
- Chart on Geographic comparison
- Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
- Chart on North America - Market size and forecast 2023-2028 ($ million)
- Data Table on North America - Market size and forecast 2023-2028 ($ million)
- Chart on North America - Year-over-year growth 2023-2028 (%)
- Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Europe - Market size and forecast 2023-2028
- Chart on Europe - Market size and forecast 2023-2028 ($ million)
- Data Table on Europe - Market size and forecast 2023-2028 ($ million)
- Chart on Europe - Year-over-year growth 2023-2028 (%)
- Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
- Chart on Asia - Market size and forecast 2023-2028 ($ million)
- Data Table on Asia - Market size and forecast 2023-2028 ($ million)
- Chart on Asia - Year-over-year growth 2023-2028 (%)
- Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
- Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
- Chart on US - Market size and forecast 2023-2028 ($ million)
- Data Table on US - Market size and forecast 2023-2028 ($ million)
- Chart on US - Year-over-year growth 2023-2028 (%)
- Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 France - Market size and forecast 2023-2028
- Chart on France - Market size and forecast 2023-2028 ($ million)
- Data Table on France - Market size and forecast 2023-2028 ($ million)
- Chart on France - Year-over-year growth 2023-2028 (%)
- Data Table on France - Year-over-year growth 2023-2028 (%)
9.9 Norway - Market size and forecast 2023-2028
- Chart on Norway - Market size and forecast 2023-2028 ($ million)
- Data Table on Norway - Market size and forecast 2023-2028 ($ million)
- Chart on Norway - Year-over-year growth 2023-2028 (%)
- Data Table on Norway - Year-over-year growth 2023-2028 (%)
9.10 UK - Market size and forecast 2023-2028
- Chart on UK - Market size and forecast 2023-2028 ($ million)
- Data Table on UK - Market size and forecast 2023-2028 ($ million)
- Chart on UK - Year-over-year growth 2023-2028 (%)
- Data Table on UK - Year-over-year growth 2023-2028 (%)
9.11 Japan - Market size and forecast 2023-2028
- Chart on Japan - Market size and forecast 2023-2028 ($ million)
- Data Table on Japan - Market size and forecast 2023-2028 ($ million)
- Chart on Japan - Year-over-year growth 2023-2028 (%)
- Data Table on Japan - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity By Geographical Landscape
- Market opportunity By Geographical Landscape ($ million)
- Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Opportunity/Restraints

10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2023 and 2028
10.4 Market opportunities/restraints

11 Competitive Landscape

11.1 Overview
11.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
11.3 Landscape disruption
- Overview on factors of disruption
11.4 Industry risks
- Impact of key risks on business

12 Competitive Analysis

12.1 Companies profiled
- Companies covered
12.2 Market positioning of companies
- Matrix on companies position and classification
12.3 AbbVie Inc.
- AbbVie Inc. - Overview
- AbbVie Inc. - Product / Service
- AbbVie Inc. - Key news
- AbbVie Inc. - Key offerings
12.4 Amgen Inc.
- Amgen Inc. - Overview
- Amgen Inc. - Product / Service
- Amgen Inc. - Key news
- Amgen Inc. - Key offerings
12.5 Anthos Therapeutics
- Anthos Therapeutics - Overview
- Anthos Therapeutics - Product / Service
- Anthos Therapeutics - Key offerings
12.6 Bayer AG
- Bayer AG - Overview
- Bayer AG - Business segments
- Bayer AG - Key news
- Bayer AG - Key offerings
- Bayer AG - Segment focus
12.7 Boehringer Ingelheim International GmbH
- Boehringer Ingelheim International GmbH - Overview
- Boehringer Ingelheim International GmbH - Product / Service
- Boehringer Ingelheim International GmbH - Key news
- Boehringer Ingelheim International GmbH - Key offerings
12.8 Bristol Myers Squibb Co.
- Bristol Myers Squibb Co. - Overview
- Bristol Myers Squibb Co. - Product / Service
- Bristol Myers Squibb Co. - Key news
- Bristol Myers Squibb Co. - Key offerings
12.9 Daiichi Sankyo Co. Ltd.
- Daiichi Sankyo Co. Ltd. - Overview
- Daiichi Sankyo Co. Ltd. - Product / Service
- Daiichi Sankyo Co. Ltd. - Key news
- Daiichi Sankyo Co. Ltd. - Key offerings
12.10 Eli Lilly and Co.
- Eli Lilly and Co. - Overview
- Eli Lilly and Co. - Product / Service
- Eli Lilly and Co. - Key news
- Eli Lilly and Co. - Key offerings
12.11 F. Hoffmann La Roche Ltd.
- F. Hoffmann La Roche Ltd. - Overview
- F. Hoffmann La Roche Ltd. - Business segments
- F. Hoffmann La Roche Ltd. - Key news
- F. Hoffmann La Roche Ltd. - Key offerings
- F. Hoffmann La Roche Ltd. - Segment focus
12.12 Gilead Sciences Inc.
- Gilead Sciences Inc. - Overview
- Gilead Sciences Inc. - Product / Service
- Gilead Sciences Inc. - Key news
- Gilead Sciences Inc. - Key offerings
12.13 Inari Medical Inc.
- Inari Medical Inc. - Overview
- Inari Medical Inc. - Product / Service
- Inari Medical Inc. - Key offerings
12.14 Johnson and Johnson Services Inc.
- Johnson and Johnson Services Inc. - Overview
- Johnson and Johnson Services Inc. - Business segments
- Johnson and Johnson Services Inc. - Key news
- Johnson and Johnson Services Inc. - Key offerings
- Johnson and Johnson Services Inc. - Segment focus
12.15 Pfizer Inc.
- Pfizer Inc. - Overview
- Pfizer Inc. - Product / Service
- Pfizer Inc. - Key news
- Pfizer Inc. - Key offerings
12.16 Sanofi SA
- Sanofi SA - Overview
- Sanofi SA - Business segments
- Sanofi SA - Key news
- Sanofi SA - Key offerings
- Sanofi SA - Segment focus
12.17 Takeda Pharmaceutical Co. Ltd.
- Takeda Pharmaceutical Co. Ltd. - Overview
- Takeda Pharmaceutical Co. Ltd. - Product / Service
- Takeda Pharmaceutical Co. Ltd. - Key news
- Takeda Pharmaceutical Co. Ltd. - Key offerings

13 Appendix

13.1 Scope of the report
13.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
13.3 Currency conversion rates for US$
- Currency conversion rates for US$
13.4 Research methodology
- Research methodology
13.5 Data procurement
- Information sources
13.6 Data validation
- Data validation
13.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
13.8 Data synthesis
- Data synthesis
13.9 360 degree market analysis
- 360 degree market analysis
13.10 List of abbreviations
- List of abbreviations

Product Code: IRTNTR75721

Exhibits:

Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Application
Exhibits6: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Company Market Positioning
Exhibits10: Parent Market
Exhibits11: Data Table on - Parent Market
Exhibits12: Market characteristics analysis
Exhibits13: Value Chain Analysis
Exhibits14: Offerings of companies included in the market definition
Exhibits15: Market segments
Exhibits16: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibits17: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibits18: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits19: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits20: Historic Market Size - Data Table on Global Pulmonary Embolism Therapeutics Market 2018 - 2022 ($ million)
Exhibits21: Historic Market Size - Application Segment 2018 - 2022 ($ million)
Exhibits22: Historic Market Size - Route of Administration Segment 2018 - 2022 ($ million)
Exhibits23: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
Exhibits24: Historic Market Size - Country Segment 2018 - 2022 ($ million)
Exhibits25: Five forces analysis - Comparison between 2023 and 2028
Exhibits26: Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits27: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits28: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits29: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits30: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits31: Chart on Market condition - Five forces 2023 and 2028
Exhibits32: Chart on Application - Market share 2023-2028 (%)
Exhibits33: Data Table on Application - Market share 2023-2028 (%)
Exhibits34: Chart on Comparison by Application
Exhibits35: Data Table on Comparison by Application
Exhibits36: Chart on Hospitals - Market size and forecast 2023-2028 ($ million)
Exhibits37: Data Table on Hospitals - Market size and forecast 2023-2028 ($ million)
Exhibits38: Chart on Hospitals - Year-over-year growth 2023-2028 (%)
Exhibits39: Data Table on Hospitals - Year-over-year growth 2023-2028 (%)
Exhibits40: Chart on Ambulatory surgical centers - Market size and forecast 2023-2028 ($ million)
Exhibits41: Data Table on Ambulatory surgical centers - Market size and forecast 2023-2028 ($ million)
Exhibits42: Chart on Ambulatory surgical centers - Year-over-year growth 2023-2028 (%)
Exhibits43: Data Table on Ambulatory surgical centers - Year-over-year growth 2023-2028 (%)
Exhibits44: Chart on Research institutes - Market size and forecast 2023-2028 ($ million)
Exhibits45: Data Table on Research institutes - Market size and forecast 2023-2028 ($ million)
Exhibits46: Chart on Research institutes - Year-over-year growth 2023-2028 (%)
Exhibits47: Data Table on Research institutes - Year-over-year growth 2023-2028 (%)
Exhibits48: Market opportunity by Application ($ million)
Exhibits49: Data Table on Market opportunity by Application ($ million)
Exhibits50: Chart on Route of Administration - Market share 2023-2028 (%)
Exhibits51: Data Table on Route of Administration - Market share 2023-2028 (%)
Exhibits52: Chart on Comparison by Route of Administration
Exhibits53: Data Table on Comparison by Route of Administration
Exhibits54: Chart on Oral - Market size and forecast 2023-2028 ($ million)
Exhibits55: Data Table on Oral - Market size and forecast 2023-2028 ($ million)
Exhibits56: Chart on Oral - Year-over-year growth 2023-2028 (%)
Exhibits57: Data Table on Oral - Year-over-year growth 2023-2028 (%)
Exhibits58: Chart on Parenteral - Market size and forecast 2023-2028 ($ million)
Exhibits59: Data Table on Parenteral - Market size and forecast 2023-2028 ($ million)
Exhibits60: Chart on Parenteral - Year-over-year growth 2023-2028 (%)
Exhibits61: Data Table on Parenteral - Year-over-year growth 2023-2028 (%)
Exhibits62: Market opportunity by Route of Administration ($ million)
Exhibits63: Data Table on Market opportunity by Route of Administration ($ million)
Exhibits64: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits65: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits66: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits67: Chart on Geographic comparison
Exhibits68: Data Table on Geographic comparison
Exhibits69: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibits70: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibits71: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits72: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits73: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits74: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits75: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits76: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits77: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits78: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits79: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits80: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits81: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits82: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits83: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits84: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits85: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibits86: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibits87: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits88: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits89: Chart on France - Market size and forecast 2023-2028 ($ million)
Exhibits90: Data Table on France - Market size and forecast 2023-2028 ($ million)
Exhibits91: Chart on France - Year-over-year growth 2023-2028 (%)
Exhibits92: Data Table on France - Year-over-year growth 2023-2028 (%)
Exhibits93: Chart on Norway - Market size and forecast 2023-2028 ($ million)
Exhibits94: Data Table on Norway - Market size and forecast 2023-2028 ($ million)
Exhibits95: Chart on Norway - Year-over-year growth 2023-2028 (%)
Exhibits96: Data Table on Norway - Year-over-year growth 2023-2028 (%)
Exhibits97: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibits98: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibits99: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits100: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits101: Chart on Japan - Market size and forecast 2023-2028 ($ million)
Exhibits102: Data Table on Japan - Market size and forecast 2023-2028 ($ million)
Exhibits103: Chart on Japan - Year-over-year growth 2023-2028 (%)
Exhibits104: Data Table on Japan - Year-over-year growth 2023-2028 (%)
Exhibits105: Market opportunity By Geographical Landscape ($ million)
Exhibits106: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits107: Impact of drivers and challenges in 2023 and 2028
Exhibits108: Overview on criticality of inputs and factors of differentiation
Exhibits109: Overview on factors of disruption
Exhibits110: Impact of key risks on business
Exhibits111: Companies covered
Exhibits112: Matrix on companies position and classification
Exhibits113: AbbVie Inc. - Overview
Exhibits114: AbbVie Inc. - Product / Service
Exhibits115: AbbVie Inc. - Key news
Exhibits116: AbbVie Inc. - Key offerings
Exhibits117: Amgen Inc. - Overview
Exhibits118: Amgen Inc. - Product / Service
Exhibits119: Amgen Inc. - Key news
Exhibits120: Amgen Inc. - Key offerings
Exhibits121: Anthos Therapeutics - Overview
Exhibits122: Anthos Therapeutics - Product / Service
Exhibits123: Anthos Therapeutics - Key offerings
Exhibits124: Bayer AG - Overview
Exhibits125: Bayer AG - Business segments
Exhibits126: Bayer AG - Key news
Exhibits127: Bayer AG - Key offerings
Exhibits128: Bayer AG - Segment focus
Exhibits129: Boehringer Ingelheim International GmbH - Overview
Exhibits130: Boehringer Ingelheim International GmbH - Product / Service
Exhibits131: Boehringer Ingelheim International GmbH - Key news
Exhibits132: Boehringer Ingelheim International GmbH - Key offerings
Exhibits133: Bristol Myers Squibb Co. - Overview
Exhibits134: Bristol Myers Squibb Co. - Product / Service
Exhibits135: Bristol Myers Squibb Co. - Key news
Exhibits136: Bristol Myers Squibb Co. - Key offerings
Exhibits137: Daiichi Sankyo Co. Ltd. - Overview
Exhibits138: Daiichi Sankyo Co. Ltd. - Product / Service
Exhibits139: Daiichi Sankyo Co. Ltd. - Key news
Exhibits140: Daiichi Sankyo Co. Ltd. - Key offerings
Exhibits141: Eli Lilly and Co. - Overview
Exhibits142: Eli Lilly and Co. - Product / Service
Exhibits143: Eli Lilly and Co. - Key news
Exhibits144: Eli Lilly and Co. - Key offerings
Exhibits145: F. Hoffmann La Roche Ltd. - Overview
Exhibits146: F. Hoffmann La Roche Ltd. - Business segments
Exhibits147: F. Hoffmann La Roche Ltd. - Key news
Exhibits148: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits149: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits150: Gilead Sciences Inc. - Overview
Exhibits151: Gilead Sciences Inc. - Product / Service
Exhibits152: Gilead Sciences Inc. - Key news
Exhibits153: Gilead Sciences Inc. - Key offerings
Exhibits154: Inari Medical Inc. - Overview
Exhibits155: Inari Medical Inc. - Product / Service
Exhibits156: Inari Medical Inc. - Key offerings
Exhibits157: Johnson and Johnson Services Inc. - Overview
Exhibits158: Johnson and Johnson Services Inc. - Business segments
Exhibits159: Johnson and Johnson Services Inc. - Key news
Exhibits160: Johnson and Johnson Services Inc. - Key offerings
Exhibits161: Johnson and Johnson Services Inc. - Segment focus
Exhibits162: Pfizer Inc. - Overview
Exhibits163: Pfizer Inc. - Product / Service
Exhibits164: Pfizer Inc. - Key news
Exhibits165: Pfizer Inc. - Key offerings
Exhibits166: Sanofi SA - Overview
Exhibits167: Sanofi SA - Business segments
Exhibits168: Sanofi SA - Key news
Exhibits169: Sanofi SA - Key offerings
Exhibits170: Sanofi SA - Segment focus
Exhibits171: Takeda Pharmaceutical Co. Ltd. - Overview
Exhibits172: Takeda Pharmaceutical Co. Ltd. - Product / Service
Exhibits173: Takeda Pharmaceutical Co. Ltd. - Key news
Exhibits174: Takeda Pharmaceutical Co. Ltd. - Key offerings
Exhibits175: Inclusions checklist
Exhibits176: Exclusions checklist
Exhibits177: Currency conversion rates for US$
Exhibits178: Research methodology
Exhibits179: Information sources
Exhibits180: Data validation
Exhibits181: Validation techniques employed for market sizing
Exhibits182: Data synthesis
Exhibits183: 360 degree market analysis
Exhibits184: List of abbreviations